Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States

被引：0
|
作者：
Sammy Saab
Suchin Virabhak
Hélène Parisé
Scott Johnson
Alice Wang
Derek Misurski
Yuri Sanchez Gonzalez
Timothy Juday
机构：
[1] Pfleger Liver Institute,Health Economics and Outcomes Research
[2] UCLA,undefined
[3] Medicus Economics LLC,undefined
[4] AbbVie,undefined
[5] Inc.,undefined
来源：
Advances in Therapy | 2016年 / 33卷
关键词：
Cost-effectiveness; Direct-acting antivirals; Hepatitis C virus; Human immunodeficiency virus; Infectious diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1316 / 1330
页数：14
相关论文
共 50 条
  • [1] Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States
    Saab, Sammy
    Virabhak, Suchin
    Parise, Helene
    Johnson, Scott
    Wang, Alice
    Misurski, Derek
    Gonzalez, Yuri Sanchez
    Juday, Timothy
    ADVANCES IN THERAPY, 2016, 33 (08) : 1316 - 1330
  • [2] Cost-effectiveness of treatment for chronic hepatitis C infection in patients coinfected with human immunodeficiency virus
    Servoss, JC
    Campos, NG
    Salomon, JA
    Freedberg, KA
    Samet, JH
    Goldie, SJ
    Chung, RT
    HEPATOLOGY, 2005, 42 (04) : 350A - 350A
  • [3] The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Linas, Benjamin P.
    Barter, Devra M.
    Leff, Jared A.
    DiLorenzo, Madeline
    Schackman, Bruce R.
    Horsburgh, Charles R.
    Assoumou, Sabrina A.
    Salomon, Joshua A.
    Weinstein, Milton C.
    Kim, Arthur Y.
    Freedberg, Kenneth A.
    AIDS, 2014, 28 (03) : 365 - 376
  • [4] Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States
    Hyle, Emily P.
    Scott, Justine A.
    Sax, Paul E.
    Millham, Lucia R., I
    Dugdale, Caitlin M.
    Weinstein, Milton C.
    Freedberg, Kenneth A.
    Walensky, Rochelle P.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1353 - 1363
  • [5] Fibrosis progression in chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus Reply
    Tommasini Grotto, Rejane Maria
    de Moura Campos Pardini, Maria Ines
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (06) : 806 - 807
  • [6] Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus
    Martinez-Sierra, C
    Arizcorreta, A
    Díaz, F
    Roldán, R
    Martín-Herrera, L
    Pérez-Guzmán, E
    Girón-González, JA
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) : 491 - 498
  • [7] Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States
    Chhatwal, Jagpreet
    Ferrante, Shannon A.
    Brass, Cliff
    El Khoury, Antoine C.
    Burroughs, Margaret
    Bacon, Bruce
    Esteban-Mur, Rafael
    Elbasha, Elamin H.
    VALUE IN HEALTH, 2013, 16 (06) : 973 - 986
  • [8] Treatment for hepatitis C virus in human immunodeficiency virus-infected patients - Clinical benefits and cost-effectiveness
    Kuehne, FC
    Bethe, U
    Freedberg, K
    Goldie, SJ
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (22) : 2545 - 2556
  • [9] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay, O. U.
    McMullen, M.
    Rey Ares, L.
    Idrovo, V
    Prieto Ortiz, J.
    Tapias, M.
    Obregon, J.
    Ariza, J. G.
    Caporale, J.
    VALUE IN HEALTH, 2013, 16 (07) : A693 - A693
  • [10] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay, O. U.
    McMullen, M.
    Rey Ares, L.
    Obando, C. A.
    Caporale, J.
    VALUE IN HEALTH, 2013, 16 (07) : A714 - A714
12345